| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 5 | 2022 | 1103 | 1.010 |
Why?
|
| Fasting | 1 | 2024 | 54 | 0.960 |
Why?
|
| Chemokines | 2 | 2016 | 97 | 0.940 |
Why?
|
| Disease Progression | 4 | 2024 | 601 | 0.930 |
Why?
|
| Cell Cycle | 1 | 2024 | 326 | 0.860 |
Why?
|
| Butyrates | 3 | 2016 | 31 | 0.850 |
Why?
|
| Students | 2 | 2023 | 519 | 0.740 |
Why?
|
| Copper | 3 | 2012 | 105 | 0.670 |
Why?
|
| Leukemia | 3 | 2016 | 56 | 0.660 |
Why?
|
| Syndecan-4 | 1 | 2018 | 4 | 0.660 |
Why?
|
| Durapatite | 1 | 2018 | 17 | 0.650 |
Why?
|
| Signal Transduction | 13 | 2024 | 1908 | 0.630 |
Why?
|
| Glutathione | 2 | 2012 | 179 | 0.620 |
Why?
|
| Histones | 2 | 2018 | 190 | 0.620 |
Why?
|
| Minority Groups | 1 | 2023 | 596 | 0.610 |
Why?
|
| U937 Cells | 6 | 2016 | 27 | 0.610 |
Why?
|
| Exosomes | 1 | 2018 | 101 | 0.570 |
Why?
|
| Tyrosine | 5 | 1999 | 118 | 0.570 |
Why?
|
| Inflammation | 2 | 2024 | 618 | 0.560 |
Why?
|
| Gene Expression | 2 | 2016 | 674 | 0.540 |
Why?
|
| Obesity | 1 | 2024 | 1067 | 0.540 |
Why?
|
| Prostatic Neoplasms | 6 | 2024 | 935 | 0.540 |
Why?
|
| Colonic Neoplasms | 4 | 2020 | 186 | 0.520 |
Why?
|
| Humans | 41 | 2024 | 37093 | 0.510 |
Why?
|
| Genistein | 3 | 2005 | 42 | 0.510 |
Why?
|
| Tennessee | 3 | 2022 | 70 | 0.500 |
Why?
|
| Universities | 3 | 2023 | 442 | 0.500 |
Why?
|
| Lipid Peroxides | 2 | 2005 | 17 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2024 | 269 | 0.480 |
Why?
|
| Apoptosis | 3 | 2024 | 1398 | 0.480 |
Why?
|
| Nanoparticles | 1 | 2018 | 318 | 0.470 |
Why?
|
| Benzo(a)pyrene | 4 | 2020 | 126 | 0.470 |
Why?
|
| Quercetin | 2 | 2005 | 45 | 0.460 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 2231 | 0.450 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2024 | 11 | 0.430 |
Why?
|
| I-kappa B Kinase | 1 | 2012 | 44 | 0.420 |
Why?
|
| Nickel | 1 | 2012 | 20 | 0.420 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 114 | 0.410 |
Why?
|
| Tumor Cells, Cultured | 12 | 2018 | 502 | 0.410 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2016 | 136 | 0.400 |
Why?
|
| Lipid Peroxidation | 1 | 2012 | 140 | 0.400 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2016 | 213 | 0.400 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 1999 | 132 | 0.400 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 123 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-jun | 4 | 1995 | 26 | 0.390 |
Why?
|
| Colonic Pouches | 1 | 2011 | 8 | 0.390 |
Why?
|
| S-Phase Kinase-Associated Proteins | 2 | 2024 | 16 | 0.380 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2011 | 19 | 0.380 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2008 | 103 | 0.380 |
Why?
|
| Proto-Oncogene Proteins | 4 | 1999 | 239 | 0.370 |
Why?
|
| Ovarian Neoplasms | 2 | 2016 | 312 | 0.360 |
Why?
|
| Cancer Care Facilities | 1 | 2010 | 17 | 0.360 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 122 | 0.360 |
Why?
|
| Interinstitutional Relations | 1 | 2010 | 38 | 0.360 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2011 | 92 | 0.350 |
Why?
|
| Cytokines | 2 | 2015 | 602 | 0.350 |
Why?
|
| Cell Movement | 3 | 2024 | 571 | 0.340 |
Why?
|
| Interleukin-17 | 2 | 1999 | 53 | 0.340 |
Why?
|
| Health Services Research | 1 | 2010 | 148 | 0.340 |
Why?
|
| Interleukins | 1 | 2008 | 29 | 0.320 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1997 | 40 | 0.320 |
Why?
|
| Protein Kinase C | 3 | 1998 | 120 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 99 | 0.310 |
Why?
|
| Schools, Medical | 1 | 2010 | 198 | 0.310 |
Why?
|
| Genes, jun | 3 | 1996 | 8 | 0.310 |
Why?
|
| Isoenzymes | 2 | 1998 | 161 | 0.290 |
Why?
|
| Cell Proliferation | 5 | 2024 | 1198 | 0.280 |
Why?
|
| Interleukin-11 | 2 | 1997 | 4 | 0.280 |
Why?
|
| Phosphotyrosine | 5 | 1999 | 23 | 0.280 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 1371 | 0.280 |
Why?
|
| Fetal Hemoglobin | 4 | 2003 | 14 | 0.280 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 441 | 0.260 |
Why?
|
| Iron | 2 | 2005 | 225 | 0.250 |
Why?
|
| Mice | 8 | 2024 | 5913 | 0.250 |
Why?
|
| DNA-Binding Proteins | 3 | 2020 | 539 | 0.240 |
Why?
|
| Enzyme Activation | 6 | 2008 | 444 | 0.240 |
Why?
|
| Mice, Obese | 1 | 2024 | 40 | 0.240 |
Why?
|
| Flavonoids | 1 | 2005 | 87 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-raf | 3 | 1999 | 10 | 0.240 |
Why?
|
| Linolenic Acids | 1 | 2003 | 1 | 0.230 |
Why?
|
| Health Status Disparities | 1 | 2010 | 642 | 0.230 |
Why?
|
| Phosphorylation | 9 | 1999 | 928 | 0.230 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2016 | 234 | 0.220 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1993 | 19 | 0.210 |
Why?
|
| Nuclear Proteins | 2 | 2024 | 307 | 0.210 |
Why?
|
| Blood Platelets | 3 | 1988 | 77 | 0.210 |
Why?
|
| Cell Line | 5 | 2016 | 1354 | 0.210 |
Why?
|
| Phosphoproteins | 3 | 1995 | 163 | 0.200 |
Why?
|
| Saliva | 1 | 2023 | 107 | 0.200 |
Why?
|
| United States | 2 | 2022 | 4223 | 0.200 |
Why?
|
| NF-kappa B | 2 | 2016 | 339 | 0.200 |
Why?
|
| Repressor Proteins | 2 | 2024 | 249 | 0.200 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2021 | 10 | 0.200 |
Why?
|
| Animals | 11 | 2024 | 15081 | 0.200 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 20 | 0.200 |
Why?
|
| Ubiquitination | 3 | 2023 | 61 | 0.200 |
Why?
|
| Monocytes | 3 | 2008 | 257 | 0.190 |
Why?
|
| Hydroxyurea | 2 | 2003 | 34 | 0.190 |
Why?
|
| Research Personnel | 1 | 2022 | 155 | 0.180 |
Why?
|
| Cell Membrane | 3 | 2018 | 381 | 0.180 |
Why?
|
| Atmospheric Pressure | 1 | 2020 | 11 | 0.180 |
Why?
|
| Vulnerable Populations | 1 | 2022 | 140 | 0.180 |
Why?
|
| Pressure | 1 | 2020 | 43 | 0.180 |
Why?
|
| Gene Expression Regulation | 3 | 1996 | 1015 | 0.180 |
Why?
|
| Calcium-Transporting ATPases | 3 | 1988 | 16 | 0.170 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 142 | 0.170 |
Why?
|
| Thiobarbiturates | 2 | 2012 | 4 | 0.170 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 260 | 0.160 |
Why?
|
| Extracellular Space | 1 | 2018 | 35 | 0.160 |
Why?
|
| RNA, Messenger | 4 | 2016 | 1207 | 0.160 |
Why?
|
| Trans-Activators | 1 | 1999 | 174 | 0.160 |
Why?
|
| Biotransformation | 1 | 2018 | 67 | 0.160 |
Why?
|
| Carcinogens | 2 | 2016 | 124 | 0.160 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 218 | 0.150 |
Why?
|
| Endocytosis | 1 | 2018 | 113 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 1995 | 82 | 0.150 |
Why?
|
| Hydrogen Peroxide | 2 | 2012 | 190 | 0.150 |
Why?
|
| RNA Interference | 1 | 2018 | 243 | 0.150 |
Why?
|
| Kinetics | 6 | 1998 | 708 | 0.150 |
Why?
|
| Interleukin-15 | 1 | 1997 | 13 | 0.150 |
Why?
|
| Ligands | 1 | 2018 | 349 | 0.150 |
Why?
|
| Liver | 1 | 2020 | 479 | 0.150 |
Why?
|
| Leukemia, Erythroblastic, Acute | 4 | 2003 | 10 | 0.150 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2016 | 5 | 0.140 |
Why?
|
| src-Family Kinases | 1 | 1997 | 46 | 0.140 |
Why?
|
| Cell Differentiation | 6 | 2015 | 587 | 0.140 |
Why?
|
| Chemokine CCL20 | 1 | 2016 | 7 | 0.140 |
Why?
|
| Erythroid Precursor Cells | 2 | 1998 | 7 | 0.140 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2016 | 20 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 807 | 0.140 |
Why?
|
| HL-60 Cells | 1 | 2016 | 32 | 0.140 |
Why?
|
| Valproic Acid | 1 | 2016 | 16 | 0.140 |
Why?
|
| Chemokine CCL5 | 1 | 2016 | 39 | 0.140 |
Why?
|
| Erythropoietin | 1 | 1996 | 39 | 0.140 |
Why?
|
| Transcription Factor AP-1 | 1 | 1996 | 35 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2021 | 426 | 0.140 |
Why?
|
| Cell Survival | 2 | 2016 | 864 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 95 | 0.140 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2015 | 6 | 0.130 |
Why?
|
| Blotting, Western | 5 | 1999 | 859 | 0.130 |
Why?
|
| Genes, APC | 1 | 2015 | 14 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 1039 | 0.130 |
Why?
|
| Caspase 3 | 1 | 2016 | 207 | 0.130 |
Why?
|
| Recombinant Proteins | 4 | 1999 | 515 | 0.130 |
Why?
|
| Calcium | 3 | 1988 | 480 | 0.130 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 147 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2015 | 118 | 0.130 |
Why?
|
| Interleukin-13 | 1 | 1995 | 19 | 0.130 |
Why?
|
| Antioxidants | 3 | 2018 | 416 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2015 | 95 | 0.120 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 2 | 2005 | 15 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 515 | 0.120 |
Why?
|
| Female | 4 | 2024 | 20969 | 0.110 |
Why?
|
| Oxidation-Reduction | 2 | 2005 | 431 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 40 | 0.110 |
Why?
|
| Ethers, Cyclic | 1 | 1992 | 5 | 0.110 |
Why?
|
| Edetic Acid | 1 | 2012 | 23 | 0.110 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1992 | 46 | 0.100 |
Why?
|
| Cell Division | 5 | 2003 | 307 | 0.100 |
Why?
|
| Male | 8 | 2024 | 20025 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 356 | 0.090 |
Why?
|
| Protein Kinases | 2 | 1988 | 100 | 0.090 |
Why?
|
| Colitis, Ulcerative | 1 | 2011 | 54 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2010 | 81 | 0.090 |
Why?
|
| Research Support as Topic | 1 | 2010 | 80 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 172 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2015 | 938 | 0.090 |
Why?
|
| Benzamidines | 2 | 2000 | 5 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2010 | 117 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2011 | 238 | 0.090 |
Why?
|
| Risk Factors | 2 | 2023 | 3562 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2023 | 933 | 0.080 |
Why?
|
| Butadienes | 1 | 2008 | 29 | 0.080 |
Why?
|
| Nitriles | 1 | 2008 | 69 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 219 | 0.080 |
Why?
|
| Incidence | 1 | 2011 | 922 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 1988 | 76 | 0.080 |
Why?
|
| Enzyme Inhibitors | 3 | 2000 | 433 | 0.080 |
Why?
|
| Butyric Acid | 2 | 1998 | 18 | 0.080 |
Why?
|
| Heart | 1 | 1988 | 180 | 0.070 |
Why?
|
| Transcription Factors | 1 | 1991 | 681 | 0.070 |
Why?
|
| Genes, fos | 2 | 1995 | 14 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2008 | 513 | 0.070 |
Why?
|
| Sugar Phosphates | 1 | 1985 | 5 | 0.070 |
Why?
|
| Inositol Phosphates | 1 | 1985 | 8 | 0.070 |
Why?
|
| Transfection | 2 | 2016 | 523 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2005 | 177 | 0.060 |
Why?
|
| K562 Cells | 2 | 2003 | 32 | 0.060 |
Why?
|
| Time Factors | 2 | 1999 | 1742 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2023 | 4 | 0.060 |
Why?
|
| Ferrous Compounds | 1 | 2003 | 20 | 0.060 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2023 | 43 | 0.060 |
Why?
|
| Monosaccharides | 1 | 2003 | 11 | 0.060 |
Why?
|
| Ions | 1 | 2003 | 61 | 0.060 |
Why?
|
| Urea | 1 | 2003 | 41 | 0.060 |
Why?
|
| Drug Stability | 1 | 2003 | 116 | 0.060 |
Why?
|
| Lysosomes | 1 | 2023 | 91 | 0.050 |
Why?
|
| Intracellular Membranes | 2 | 1997 | 38 | 0.050 |
Why?
|
| Ribonucleotide Reductases | 2 | 2000 | 8 | 0.050 |
Why?
|
| alpha-Fetoproteins | 1 | 2022 | 31 | 0.050 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2021 | 9 | 0.050 |
Why?
|
| Molecular Weight | 2 | 1993 | 167 | 0.050 |
Why?
|
| Hemoglobin, Sickle | 1 | 2000 | 13 | 0.050 |
Why?
|
| Porosity | 1 | 2020 | 32 | 0.050 |
Why?
|
| Streptozocin | 1 | 2000 | 21 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2000 | 32 | 0.040 |
Why?
|
| Solvents | 1 | 2020 | 99 | 0.040 |
Why?
|
| TYK2 Kinase | 1 | 1999 | 2 | 0.040 |
Why?
|
| STAT2 Transcription Factor | 1 | 1999 | 2 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2020 | 167 | 0.040 |
Why?
|
| STAT4 Transcription Factor | 1 | 1999 | 3 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 121 | 0.040 |
Why?
|
| Receptors, Interleukin-17 | 1 | 1999 | 9 | 0.040 |
Why?
|
| Receptors, Interleukin | 1 | 1999 | 11 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 1999 | 18 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1999 | 52 | 0.040 |
Why?
|
| Janus Kinase 3 | 1 | 1999 | 35 | 0.040 |
Why?
|
| Janus Kinase 2 | 1 | 1999 | 32 | 0.040 |
Why?
|
| Base Sequence | 2 | 1992 | 997 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 1999 | 35 | 0.040 |
Why?
|
| Protein Kinase C-epsilon | 1 | 1998 | 14 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 1999 | 90 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1998 | 53 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 1999 | 92 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 1992 | 1568 | 0.040 |
Why?
|
| DNA Adducts | 1 | 2018 | 42 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1455 | 0.040 |
Why?
|
| Carcinogens, Environmental | 1 | 2018 | 35 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2018 | 88 | 0.040 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2018 | 51 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2018 | 207 | 0.040 |
Why?
|
| Calmodulin | 2 | 1988 | 46 | 0.040 |
Why?
|
| Water | 1 | 2020 | 296 | 0.040 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1997 | 7 | 0.040 |
Why?
|
| Peritoneal Cavity | 1 | 2016 | 6 | 0.040 |
Why?
|
| Cytosol | 1 | 1997 | 93 | 0.040 |
Why?
|
| Chemokine CXCL1 | 1 | 2016 | 15 | 0.040 |
Why?
|
| Protein Stability | 1 | 2016 | 45 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 51 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 1997 | 89 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 90 | 0.040 |
Why?
|
| Rats, Mutant Strains | 1 | 2016 | 6 | 0.040 |
Why?
|
| Biological Transport | 1 | 1997 | 185 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 54 | 0.040 |
Why?
|
| Proteins | 1 | 1999 | 369 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 136 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1996 | 29 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 113 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1996 | 212 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fes | 1 | 1995 | 3 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 337 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 133 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 148 | 0.030 |
Why?
|
| Isoflavones | 1 | 1996 | 129 | 0.030 |
Why?
|
| Prostate | 1 | 2016 | 154 | 0.030 |
Why?
|
| Hydroquinones | 1 | 1995 | 8 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2721 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 201 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 204 | 0.030 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1993 | 10 | 0.030 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1993 | 19 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 1993 | 41 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1992 | 22 | 0.030 |
Why?
|
| Okadaic Acid | 1 | 1992 | 15 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1992 | 62 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1991 | 24 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1993 | 213 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1991 | 41 | 0.020 |
Why?
|
| Staurosporine | 1 | 1991 | 38 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1991 | 150 | 0.020 |
Why?
|
| Alkaloids | 1 | 1991 | 39 | 0.020 |
Why?
|
| Plasmids | 1 | 1991 | 246 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 1993 | 1518 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1988 | 11 | 0.020 |
Why?
|
| Calcimycin | 1 | 1988 | 12 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 3483 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1991 | 578 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 1988 | 131 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1987 | 96 | 0.020 |
Why?
|
| Homeostasis | 1 | 1987 | 188 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1985 | 6 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 1985 | 26 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1988 | 517 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 227 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1998 | 50 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2000 | 803 | 0.010 |
Why?
|